|Articles|July 1, 2017
- Pharmaceutical Executive-07-01-2017
- Volume 37
- Issue 7
Pharmaceutical Executive, July 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Building a Digital Health Infrastructureover 8 years ago
Patient Insights in the Age of AIover 8 years ago
Pharma Raises Stakes in Digital Healthover 8 years ago
Removing Uncertainty from the Drug Insurance Conversationover 8 years ago
Reflections from DIAover 8 years ago
Can AI Improve Sales Productivity in Pharma?over 8 years ago
Improving Patients’ Lives and Boosting Mature Product Portfoliosover 8 years ago
Reinventing the Role of Medical Affairsover 8 years ago
Beyond KOL Marketing: Tapping Digital Opinion Influencersover 8 years ago
There’s a Digital Health App for That!Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
2
Pharma Companies Shift Towards Direct-To-Consumer Sales in US Amidst Tariff and Pricing Turmoil
3
How are the Drug Pricing Negotiations Impacting Pharma's Relationship with DC?
4
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
5
